146 related articles for article (PubMed ID: 11363697)
1. Saquinavir plus ddC reduces deaths by more than two-thirds.
J Int Assoc Physicians AIDS Care; 1996 Jun; 2(6):51. PubMed ID: 11363697
[TBL] [Abstract][Full Text] [Related]
2. Saquinavir: combination shows survival benefit; new formulation trial recruiting.
AIDS Treat News; 1996 May; (no 246):1-2. PubMed ID: 11363484
[TBL] [Abstract][Full Text] [Related]
3. Saquinavir prolongs survival and slows disease progression.
BETA; 1996 Jun; ():6. PubMed ID: 11363649
[TBL] [Abstract][Full Text] [Related]
4. Protease inhibitors and prevention of cross resistance.
Levin J
AIDS Treat News; 1995 Oct; (no 232):1-3. PubMed ID: 11362875
[TBL] [Abstract][Full Text] [Related]
5. Potent new AIDS drugs underscore promise of combination therapy.
AIDS Alert; 1996 Jan; 11(1):1-4. PubMed ID: 11363225
[TBL] [Abstract][Full Text] [Related]
6. Saquinavir thwarts resistance.
AIDS Alert; 1995 Oct; 10(10):123. PubMed ID: 11362782
[TBL] [Abstract][Full Text] [Related]
7. FDA triple header. Food and Drug Administration.
Smart T
GMHC Treat Issues; 1995 Nov; 9(11):1-3. PubMed ID: 11362986
[TBL] [Abstract][Full Text] [Related]
8. Ritonavir: first to prolong survival.
MacDougall DS
J Int Assoc Physicians AIDS Care; 1996 Apr; 2(4):38-44. PubMed ID: 11363517
[TBL] [Abstract][Full Text] [Related]
9. Saquinavir gets accelerated approval.
McGuire S
Posit Aware; 1996; 7(1):8. PubMed ID: 11363135
[TBL] [Abstract][Full Text] [Related]
10. No tease this time--pros and cons of a long-awaited anti-HIV drug.
Chang HE
Posit Aware; 1996; 7(1):18-20. PubMed ID: 11363118
[TBL] [Abstract][Full Text] [Related]
11. Roche submits NDA for Invirase.
J Int Assoc Physicians AIDS Care; 1995 Sep; 1(8):37-8. PubMed ID: 11362796
[TBL] [Abstract][Full Text] [Related]
12. A kinder, gentler ddC... for $7,200 a year.
GMHC Treat Issues; 1995 Dec; 9(12):2. PubMed ID: 11362996
[TBL] [Abstract][Full Text] [Related]
13. Protease inhibitor update: treatment combination strategies.
Mascolini M
AIDS Treat News; 1996 Jan; (no 239):3. PubMed ID: 11363085
[TBL] [Abstract][Full Text] [Related]
14. 3TC and saquinavir: we need them now.
Baker R
BETA; 1995 Sep; ():3. PubMed ID: 11362889
[TBL] [Abstract][Full Text] [Related]
15. Drug-resistance patterns of saquinavir and other HIV proteinase inhibitors.
Roberts NA
AIDS; 1995 Dec; 9 Suppl 2():27-S32. PubMed ID: 8775804
[TBL] [Abstract][Full Text] [Related]
16. Drug companies seek trial participants.
AIDS Alert; 1995 Jun; 10(6):82. PubMed ID: 11362432
[TBL] [Abstract][Full Text] [Related]
17. Two protease inhibitors given high expectations.
AIDS Alert; 1996 Jun; 11(6):63. PubMed ID: 11363541
[TBL] [Abstract][Full Text] [Related]
18. Saquinavir: major study shows survival benefit in treatment-naive patients.
James JS
AIDS Treat News; 1997 Jul; (No 274):6. PubMed ID: 11364463
[TBL] [Abstract][Full Text] [Related]
19. Lottery opens 2,000 slots for protease trial.
AIDS Alert; 1995 Nov; 10(11):144. PubMed ID: 11362929
[TBL] [Abstract][Full Text] [Related]
20. Major protease inhibitor triple combination trial begins soon: CD4 under 200, AZT experienced, 3TC naive.
James JS
AIDS Treat News; 1995 Dec; (no 237):3. PubMed ID: 11363075
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
